New COVID-19 test reduces testing time from 30 minutes to five
University of Birmingham researchers have invented a COVID-19 test that reduces testing time from 30 minutes to under five, whilst still delivering accurate results. The...
Rollout of Oxford/AstraZeneca COVID-19 vaccine begins
Patients at Oxford University Hospital have been the very first to receive the Oxford/AstraZeneca coronavirus vaccine today, as the NHS begins its rollout programme. At...
Oxford University/AstraZeneca COVID-19 vaccine approved for use in UK
The UK Government has accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise Oxford University/AstraZeneca’s COVID-19 vaccine for use. The...
Global team of scientists unite to assess role of T cells in COVID-19 battle
The Global T cell Expert Consortium (GTEC) has been established to analyse evidence that T cell response is the critical next frontier in detecting,...
Pfizer and BioNTech receive EU authorisation for COVID-19 vaccine Comirnaty
The European Commission (EC) has granted a conditional marketing authorisation (CMA) to Pfizer and BioNTech’s COVID-19 vaccine under the new name Comirnaty. Also known as...
BAME communities under-represented in COVID-19 clinical research
The National Institute for Health Research (NIHR) has published data on participation in COVID-19 urgent public health research by ethnicity. Black, Asian or other...
NHS England announces network of ‘long COVID’ clinics
NHS England has invested £10 million in a network of clinics offering specialist support to thousands of patients suffering with the long-term symptoms of...
Oxford AstraZeneca COVID-19 vaccine confirmed as safe and effective
Following on from the results of the Phase I/II trial of the Oxford AstraZeneca COVID-19 vaccine published in the scientific journal The Lancet, results...
Nasal spray to protect against COVID-19 is ready for use in humans
A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using compounds already...
Implications of early COVID-19 vaccine data
News this week has largely been dominated by talk about a COVID-19 vaccine and finnCap’s Rude Health Life Sciences Sector Report is one of...
Latest articles
Merck discontinues development of its COVID-19 vaccines
Merck, known as MSD outside the United States and Canada, has announced that the company is discontinuing development of its two COVID-19 vaccine candidates,...
COVID-19 vaccination programme ramps up with 30 new centres
More than 30 new NHS Vaccine Centres will start delivering COVID-19 jabs this week as the health service continues to accelerate the biggest immunisation...
Isle of Man set to become world-leading exporter of medicinal cannabis
The Isle of Man Government has passed new regulations to create a comprehensive framework to issue licenses for the production, distribution and export of...
Popular articles
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Nasal spray to protect against COVID-19 is ready for use in humans
A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using compounds already...
JCVI updates priority list for COVID-19 vaccine
The Joint Committee on Vaccination and Immunisation (JCVI) has advised that the first priorities for any COVID-19 vaccination programme should be the prevention of...
Isle of Man set to become world-leading exporter of medicinal cannabis
The Isle of Man Government has passed new regulations to create a comprehensive framework to issue licenses for the production, distribution and export of...